https://www.selleckchem.com/pr....oducts/asciminib-abl
The assay has been optimized to meet high-throughput screening (HTS) criteria in multiday variability studies. To control for batch-to-batch variation in the primary MEFs, we have implemented a screening strategy that employs sentinel cells to avoid costly losses during HTS. We posit the assay will identify bona fide suppressors of lamin B1 pathophysiology as candidates for development into potential therapies for ADLD.Rationale Maintaining iron homeostasis is essential for proper cardiac function. Both iron deficiency and iron